Industry News

Join WhatsApp Channel

26 June 2025

Eli Lilly Launches Mounjaro KwikPen in India to Rival Novo Nordisk Wegovy

As reported by Reuters, U.S. pharmaceutical giant Eli Lilly has launched its Mounjaro KwikPen in India, expanding its portfolio of treatments for diabetes and obesity.
26 June 2025

Lupin Launches Generic Prucalopride Tablets in U.S. for Chronic Constipation Treatment

Lupin Limited, a leading global pharmaceutical company, has announced the launch of its Prucalopride Tablets in 1 mg and 2 mg strengths in the United States, following the recent approval of its Abbreviated New Drug Application (ANDA) by the U.S. Food and Drug Administration (FDA).
26 June 2025

Glenmark Pharmaceuticals launches TEVIMBRA® in India, boosting access to advanced Immuno-Oncology treatments

Glenmark Pharmaceuticals Ltd., a research-driven global pharmaceutical company, has announced the launch of TEVIMBRA® (tislelizumab) in India, marking its official entry into the immuno-oncology segment.
23 June 2025

Emcure Pharmaceuticals to Fully Acquire Zuventus Healthcare

Emcure Pharmaceuticals has announced that its Board of Directors has approved a proposal to acquire the remaining 20.42% minority stake in its subsidiary, Zuventus Healthcare Ltd. The acquisition will result in Zuventus becoming a wholly owned subsidiary of Emcure.
19 June 2025

Fresenius Kabi recalls Blood Administration Sets due to life-threatening risk

Fresenius Kabi has issued an urgent nationwide recall of a specific lot of its Ivenix Large-Volume Pump (LVP) Blood Products Administration Sets, following the discovery of a manufacturing defect that could lead to serious or even fatal consequences.
18 June 2025

Glenmark Pharmaceuticals receives five observations from USFDA following Monroe facility inspection

Glenmark Pharmaceuticals Ltd. has announced that the United States Food and Drug Administration (USFDA) has completed a Good Manufacturing Practices (GMP) inspection at its manufacturing facility in Monroe, North Carolina, USA.
16 June 2025

Bristol Myers Squibb expands radiopharmaceutical pipeline through RayzeBio–Philochem Partnership

The agreement grants RayzeBio exclusive worldwide rights to Philochem’s clinical-stage radiopharmaceutical candidate OncoACP3.
14 June 2025

Amneal receives USFDA Approval for Prednisolone Acetate Ophthalmic Suspension

Amneal Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of prednisolone acetate ophthalmic suspension, 1% sterile which references Pred Forte.
13 June 2025

Apex Labs Granted Israel MoH Approval to Expand Phase 2b Macrodose Psilocybin PTSD Clinical Trial

Apex Labs Ltd. a pharmaceutical company transforming the standard of mental health care with psilocybin is pleased to announce the approval by the Israeli MoH and IRBs to open two additional clinical trial sites for SUMMIT-90.
13 June 2025

ORLADEYO® (berotralstat) approved in Colombia

BioCryst Pharmaceuticals, Inc. announced that the National Institute of Drug and Food Surveillance (INVIMA) in Colombia has granted approval for oral, once-daily ORLADEYO